| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |